WELL Health Technologies Corp.

TSX:WELL Stock Report

Market Cap: CA$1.6b

WELL Health Technologies Valuation

Is WELL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of WELL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
CA$28.31
Fair Value
78.2% undervalued intrinsic discount
14
Number of Analysts

Below Fair Value: WELL (CA$6.16) is trading below our estimate of fair value (CA$28.31)

Significantly Below Fair Value: WELL is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for WELL?

Key metric: As WELL is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for WELL. This is calculated by dividing WELL's market cap by their current earnings.
What is WELL's PE Ratio?
PE Ratio20.9x
EarningsCA$73.43m
Market CapCA$1.57b

Price to Earnings Ratio vs Peers

How does WELL's PE Ratio compare to its peers?

The above table shows the PE ratio for WELL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average68.9x
AND Andlauer Healthcare Group
27.6xn/aCA$1.8b
SIA Sienna Senior Living
42.9xn/aCA$1.3b
EXE Extendicare
14.5xn/aCA$944.8m
VHI Vitalhub
190.7x111.9%CA$618.2m
WELL WELL Health Technologies
20.9x-10.0%CA$1.6b

Price-To-Earnings vs Peers: WELL is good value based on its Price-To-Earnings Ratio (20.9x) compared to the peer average (68.9x).

Price to Earnings Ratio vs Industry

How does WELL's PE Ratio compare vs other companies in the North American Healthcare Industry?

4 CompaniesPrice / EarningsEstimated GrowthMarket Cap
WELL 20.9xIndustry Avg. 23.6xNo. of Companies10PE01632486480+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: WELL is good value based on its Price-To-Earnings Ratio (20.9x) compared to the North American Healthcare industry average (23.6x).

Price to Earnings Ratio vs Fair Ratio

What is WELL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

WELL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio20.9x
Fair PE Ratio18.4x

Price-To-Earnings vs Fair Ratio: WELL is expensive based on its Price-To-Earnings Ratio (20.9x) compared to the estimated Fair Price-To-Earnings Ratio (18.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst WELL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCA$6.16
CA$8.61
+39.7%
12.6%CA$11.00CA$7.00n/a14
Jan ’26CA$6.86
CA$8.53
+24.4%
14.3%CA$11.00CA$7.00n/a15
Dec ’25CA$5.86
CA$7.68
+31.1%
19.5%CA$10.00CA$5.25n/a15
Nov ’25CA$4.39
CA$7.55
+71.9%
19.8%CA$10.00CA$5.00n/a15
Oct ’25CA$4.40
CA$7.61
+73.0%
19.6%CA$10.00CA$5.00n/a15
Sep ’25CA$4.50
CA$7.61
+69.2%
19.6%CA$10.00CA$5.00n/a15
Aug ’25CA$4.70
CA$7.52
+60.0%
21.3%CA$10.00CA$4.75n/a14
Jul ’25CA$4.71
CA$7.52
+59.6%
21.3%CA$10.00CA$4.75n/a14
Jun ’25CA$3.75
CA$7.45
+98.7%
20.8%CA$10.00CA$4.75n/a15
May ’25CA$3.61
CA$7.39
+104.7%
20.5%CA$10.00CA$4.75n/a16
Apr ’25CA$3.67
CA$7.45
+103.1%
22.0%CA$11.00CA$4.75n/a16
Mar ’25CA$4.19
CA$7.44
+77.6%
22.2%CA$11.00CA$4.75n/a17
Feb ’25CA$3.79
CA$7.69
+102.8%
22.5%CA$11.00CA$4.75CA$5.9316
Jan ’25CA$3.85
CA$7.87
+104.3%
20.4%CA$11.00CA$5.25CA$6.8615
Dec ’24CA$3.90
CA$7.87
+101.7%
20.4%CA$11.00CA$5.25CA$5.8615
Nov ’24CA$3.68
CA$8.21
+123.2%
19.9%CA$12.00CA$5.50CA$4.3914
Oct ’24CA$4.15
CA$8.21
+97.9%
19.9%CA$12.00CA$5.50CA$4.4014
Sep ’24CA$4.76
CA$8.21
+72.6%
19.9%CA$12.00CA$5.50CA$4.5014
Aug ’24CA$4.56
CA$8.30
+82.1%
22.7%CA$13.50CA$5.50CA$4.7014
Jul ’24CA$4.75
CA$8.20
+72.6%
23.3%CA$13.50CA$5.50CA$4.7114
Jun ’24CA$5.11
CA$8.25
+61.4%
22.5%CA$13.50CA$5.50CA$3.7515
May ’24CA$5.78
CA$8.00
+38.4%
25.0%CA$13.50CA$5.00CA$3.6114
Apr ’24CA$4.86
CA$7.96
+63.8%
26.0%CA$13.50CA$5.00CA$3.6713
Mar ’24CA$4.33
CA$7.83
+80.8%
27.0%CA$13.50CA$5.00CA$4.1913
Feb ’24CA$3.67
CA$7.70
+109.7%
26.9%CA$13.50CA$5.00CA$3.7914
Analyst Price Target
Consensus Narrative from 14 Analysts
CA$8.61
Fair Value
28.4% undervalued intrinsic discount
14
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 12:52
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

WELL Health Technologies Corp. is covered by 19 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gabriel LeungBeacon Securities Limited
Douglas TaylorCanaccord Genuity
Scott FletcherCIBC Capital Markets